Homepage

physioseq_precision
WALLPAPER_UMICRO (1)

Transcriptomics, ScRNA-seq

precision medicine,
mathematical modeling,
big data analysis

target pathway analysis

glycoprofiling

microbiome sequencing

clinical studies

Process Flow

Clinical trial

On site at MAVE Body and Skin Institute, IRB-approved clinical studies (e.g. randomized control trials, discovery research) are conducted

Ancillary Studies

RNA-seq, proteomic profiling, scRNA-seq, glycoprofiling

Data analysis / model generation

Data preprocessing, feature engineering, state of the art modeling

Precision medicine

Bin patients into groups based upon probability of responding to therapy, likelihood of experiencing an adverse event, survival, etc.

Current Clients

Who we work with

Physioseq has ongoing or recently completed projects with the majority of the top 10 pharmaceutical companies and many leading academic institutions.

% top 10 pharmaceutical companies
70%
Y/Y Change
Net Operations ($) 100%

40 +

Ongoing Studies

300 +

Publications from Physioseq Scientists

500 +

Patients Enrolled